Lifecore Biomedical, Inc. traded at $7.20 this Friday February 27th, decreasing $0.17 or 2.31 percent since the previous trading session. Looking back, over the last four weeks, Lifecore Biomedical lost 15.89 percent. Over the last 12 months, its price rose by 23.29 percent. Looking ahead, we forecast Lifecore Biomedical, Inc. to be priced at 6.91 by the end of this quarter and at 6.29 in one year, according to Trading Economics global macro models projections and analysts expectations.
Landec Corporation designs, develops, manufactures, and sells differentiated products for food and biomaterials markets. The Company licenses technology applications to partners. Its two operating businesses include Curation Foods, Inc. (Curation Foods) and Lifecore Biomedical, Inc. (Lifecore). Curation Foods is engaged in processing, marketing, and selling of fresh packaged plant-based salads and vegetables. Curation Foods brands include Eat Smart, O Olive Oil & Vinegar, Yucatan & Cabo Fresh Avocado Product, BreatheWay Packaging Technology and Windset. Lifecore is an integrated contract development and manufacturing organization (CDMO) that offers sterile, injectable pharmaceutical products in syringes and vials. Lifecore also manufactures pharmaceutical-grade sodium hyaluronate (HA). Its services include technology development, material component changes, analytical method development and formulation development.